Skip to main content
Testing version — LOERadar is in active testing. Features and data may change.
LOERadar
LOE
Radar
Hub
News
Changes
Search
Log in
Get Started
ASPRUZYO SPRINKLE (RANOLAZINE) | LOERadar
Viewing data from:
Latest
2026-07-01
2026-06-01
2026-05-01
2026-04-01
2026-03-28
2026-02-17
2026-02-10
2025-12-14
2025-02-26
2025-01-25
2024-11-08
2023-07-23
2023-06-15
2023-05-13
2023-01-26
2022-11-22
2022-10-28
2022-09-29
2022-07-09
2022-06-29
2022-04-08
2022-03-09
2021-12-28
2021-05-05
2021-03-12
2020-12-22
2020-11-12
2019-12-14
2019-09-15
ASPRUZYO SPRINKLE
NDA
Get alerts
RANOLAZINE | N216018 | SUN PHARMA INDUSTRIES LTD
2 strengths
3 unique patents
0 unique exclusivities
Patents
SEC Intel
Revenue
PTAB
Reexams
Litigation
Petitions
Trials
Price Trends
Medicare D
DMF
Approvals
Label
Products
Patent Timeline
3 unique patents by expiration date
All strengths
500MG
1GM
Active (3)
Today
2026
2027
2028
2029
2030
2031
2032
2033
2034
2035
2036
2037
2038
Today
10898444
Jan. 24, 2038
11510878
Jan. 24, 2038
12161761
Jan. 24, 2038
PTAB Proceedings
No IPR/PGR/CBM challenges found at the Patent Trial and Appeal Board
Hatch-Waxman Litigation
No ANDA patent litigation cases (NOS 835) matched from PACER
Citizen Petitions
No FDA citizen petitions matched from Regulations.gov
Products (2)
Sort:
Name
↑
Applicant
Strength
Approval
#001 — 500MG
RLD
1 patent
0 exclusivities
▴
GRANULE, EXTENDED RELEASE;ORAL | Approved: Feb 28, 2022
Patents (1)
Patent #
Expiration
PED
Drug Substance
Drug Product
Use Code
Delist
11510878
Jan 24, 2038
—
—
Yes
—
—
#002 — 1GM
RLD
3 patents
0 exclusivities
▾
GRANULE, EXTENDED RELEASE;ORAL | Approved: Feb 28, 2022